Citigroup’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.79M Sell
144,837
-160,758
-53% -$5.31M ﹤0.01% 1445
2025
Q1
$12.3M Buy
305,595
+10,465
+4% +$421K 0.01% 896
2024
Q4
$13.9M Buy
295,130
+105,285
+55% +$4.95M 0.01% 806
2024
Q3
$10M Buy
189,845
+58,491
+45% +$3.09M 0.01% 941
2024
Q2
$7.12M Sell
131,354
-32,845
-20% -$1.78M ﹤0.01% 1027
2024
Q1
$11.5M Buy
164,199
+5,225
+3% +$366K 0.01% 837
2023
Q4
$13.3M Buy
158,974
+16,260
+11% +$1.36M 0.01% 741
2023
Q3
$4.2M Sell
142,714
-32,789
-19% -$966K ﹤0.01% 1120
2023
Q2
$5.72M Sell
175,503
-50,356
-22% -$1.64M ﹤0.01% 1031
2023
Q1
$7.95M Buy
225,859
+69,332
+44% +$2.44M 0.01% 930
2022
Q4
$7.17M Sell
156,527
-3,661
-2% -$168K 0.01% 926
2022
Q3
$7.76M Buy
160,188
+24,108
+18% +$1.17M 0.01% 900
2022
Q2
$5.35M Buy
136,080
+40,400
+42% +$1.59M ﹤0.01% 1094
2022
Q1
$3.52M Sell
95,680
-77,979
-45% -$2.87M ﹤0.01% 1373
2021
Q4
$7.92M Buy
173,659
+60,249
+53% +$2.75M ﹤0.01% 1043
2021
Q3
$4.05M Sell
113,410
-128,425
-53% -$4.59M ﹤0.01% 1410
2021
Q2
$4.79M Buy
241,835
+55,089
+29% +$1.09M ﹤0.01% 1448
2021
Q1
$4.34M Buy
186,746
+164,502
+740% +$3.83M ﹤0.01% 1421
2020
Q4
$462K Buy
22,244
+13,415
+152% +$279K ﹤0.01% 2684
2020
Q3
$191K Sell
8,829
-40,714
-82% -$881K ﹤0.01% 2805
2020
Q2
$1.17M Buy
49,543
+7,941
+19% +$187K ﹤0.01% 1991
2020
Q1
$490K Sell
41,602
-2,133
-5% -$25.1K ﹤0.01% 2287
2019
Q4
$464K Sell
43,735
-57,750
-57% -$613K ﹤0.01% 2670
2019
Q3
$1.16M Buy
101,485
+21,993
+28% +$250K ﹤0.01% 2018
2019
Q2
$894K Buy
79,492
+47,114
+146% +$530K ﹤0.01% 2226
2019
Q1
$262K Sell
32,378
-99,616
-75% -$806K ﹤0.01% 2948
2018
Q4
$834K Buy
131,994
+100,664
+321% +$636K ﹤0.01% 2127
2018
Q3
$309K Sell
31,330
-91
-0.3% -$898 ﹤0.01% 2859
2018
Q2
$261K Sell
31,421
-740,900
-96% -$6.15M ﹤0.01% 2768
2018
Q1
$5.56M Sell
772,321
-46,707
-6% -$336K ﹤0.01% 925
2017
Q4
$6.68M Buy
819,028
+30,321
+4% +$247K 0.01% 839
2017
Q3
$11.4M Sell
788,707
-11,764
-1% -$171K 0.01% 641
2017
Q2
$9.69M Buy
800,471
+71,811
+10% +$869K 0.01% 646
2017
Q1
$9.36M Sell
728,660
-21,099
-3% -$271K 0.01% 644
2016
Q4
$9.11M Buy
749,759
+41,721
+6% +$507K 0.01% 691
2016
Q3
$6.5M Sell
708,038
-3,781
-0.5% -$34.7K 0.01% 731
2016
Q2
$6.76M Sell
711,819
-33,581
-5% -$319K 0.01% 658
2016
Q1
$5.26M Buy
745,400
+22,824
+3% +$161K 0.01% 799
2015
Q4
$7.56M Buy
722,576
+93,319
+15% +$976K 0.01% 686
2015
Q3
$4.21M Buy
629,257
+619,298
+6,218% +$4.14M ﹤0.01% 953
2015
Q2
$67K Buy
9,959
+6,556
+193% +$44.1K ﹤0.01% 3531
2015
Q1
$23K Sell
3,403
-5,543
-62% -$37.5K ﹤0.01% 4333
2014
Q4
$72K Buy
8,946
+4,505
+101% +$36.3K ﹤0.01% 3858
2014
Q3
$16K Buy
4,441
+3,221
+264% +$11.6K ﹤0.01% 4380
2014
Q2
$6K Sell
1,220
-6,140
-83% -$30.2K ﹤0.01% 4737
2014
Q1
$70K Sell
7,360
-2,431
-25% -$23.1K ﹤0.01% 3755
2013
Q4
$63K Buy
9,791
+7,207
+279% +$46.4K ﹤0.01% 4025
2013
Q3
$20K Sell
2,584
-16,387
-86% -$127K ﹤0.01% 4280
2013
Q2
$219K Buy
+18,971
New +$219K ﹤0.01% 2671